Here, the authors show that hepatocarcinoma cells drive the formation of semimature dendritic cells that in turn activate FcγRIIlow/− tumour B cells through the CD95L/CD95 axis, leading to the production of IL-10 and suppression of CD8 T cells. The gene discussed is CD8A; the disease is neoplasm.